The Indian biotechnology market grew 17.0% in 2009 to Rs 14,199 crore ($3.05 billion). Biopharmaceutical, BioService, BioAgri, BioIndustrial and Bioinformatics products accounted for 62%, 18%, 14%, 4% and 2% of sales, respectively. The fastest-growing sectors were BioServices and BioAgri, which each grew more than 20%. Exports increased 5.3% to account for 53% of sales, while domestic sales increased 33.8%. BioPharma products accounted for 63% of exports and BioSevices for 33%. The top 20 biotech companies represented 52% of biotech revenues and grew at an average rate of more than 22%. Fourteen of the top 20 biotech companies were domestic firms, including the top three companies: Biocon, Serum Institute of India and Panacea Biotec. The largest foreign-owned biotech companies among the top 20 were Quintiles at number 6 and NovoNordisk at number 8.

Source: BioSpectrum